期刊
ARTHRITIS AND RHEUMATISM
卷 65, 期 7, 页码 1882-1890出版社
WILEY
DOI: 10.1002/art.37966
关键词
-
类别
资金
- NIH [5T32-AI-074549-04, R01-AI-4229]
- Harvard Catalyst, the Harvard Clinical and Translational Science Center
- NIH [National Center for Research Resources and the National Center for Advancing Translational Sciences] [8UL1-TR-000170-05]
- Harvard University
- GlaxoSmithKline
- Eli Lilly
- Biogen Idec
ObjectiveTo identify microRNAs (miRNAs) in human T cells that can explain known antiinflammatory properties of steroids. MethodsActivated human CD4+ T cells from healthy donors were exposed to 1 M methylprednisolone (MP) in vitro and then subjected to miRNA and messenger RNA microarray analyses. Changes in expression profiles were recorded. Using quantitative polymerase chain reaction (qPCR), flow cytometry, and enzyme-linked immunosorbent assay (ELISA), we confirmed the suppression of predicted targets, and through miRNA transfection experiments, we could suggest mechanistic links. ResultsWe identified numerous steroid-responsive genes and miRNAsmany known and some novelincluding multiple previously unknown proinflammatory genes suppressed by MP. Further studies using qPCR, flow cytometry, and ELISA demonstrated that methylprednisolone increased the expression of miRNA-98 (miR-98) and suppressed the levels of predicted targets, including interleukin-13 and 3 tumor necrosis factor receptors (TNFRs): Fas, FasL, and TNFR superfamily member 1B. Forced expression of miR-98 in T cells resulted in suppression of the same targets. ConclusionThe findings of this study demonstrate a link between miR-98 expression and the effects of MP and provide evidence suggesting that MP acts through miR-98 to inhibit specific proinflammatory targets. Identification of this antiinflammatory mechanism of glucocorticoids is important, since it may pave the way toward the elusive goal of dissociating adverse effects from therapeutic effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据